Cargando…
Versatility and clinical effectiveness of a synthetic sealing hemostatic patch as alternative to parenchyma suturing in laparoscopic partial nephrectomy
BACKGROUND: Improvements in laparoscopic partial nephrectomy (LPN) in order to minimize perioperative warm ischemia time (WIT), complications, and consequently patient outcome are desirable. Veriset™ is a ready-to-use hemostatic patch of absorbable oxidized cellulose and hydrogel components that has...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741715/ https://www.ncbi.nlm.nih.gov/pubmed/33591449 http://dx.doi.org/10.1007/s00464-021-08333-0 |
_version_ | 1784629552800071680 |
---|---|
author | Erne, Eva Kruck, Stephan Todenhoefer, Tilman Aufderklamm, Stefan Amend, Bastian Bedke, Jens Stenzl, Arnulf Rausch, Steffen |
author_facet | Erne, Eva Kruck, Stephan Todenhoefer, Tilman Aufderklamm, Stefan Amend, Bastian Bedke, Jens Stenzl, Arnulf Rausch, Steffen |
author_sort | Erne, Eva |
collection | PubMed |
description | BACKGROUND: Improvements in laparoscopic partial nephrectomy (LPN) in order to minimize perioperative warm ischemia time (WIT), complications, and consequently patient outcome are desirable. Veriset™ is a ready-to-use hemostatic patch of absorbable oxidized cellulose and hydrogel components that has earlier been implemented in vascular and hepatic surgery. We report our experience using this device in LPN. METHODS: Patients with a solitary malignant renal mass suspicious for renal cancer underwent LPN with either the use of Veriset™ hemostatic patch (n = 40) or conventional suture technique (n = 40). Patient characteristics, operation time and WIT, postoperative course and complications were recorded retrospectively. Tumor complexity was calculated according to the R.E.N.A.L. score. Outcome was determined according to the “trifecta” criteria (negative surgical margin, WIT < 25 min, no complications within 30 days). RESULTS: No significant differences with regard to clinical parameters and median R.E.N.A.L. score (6) were observed between both groups. Operation time (mean 127.1 min vs. 162. 8 min; p = 0.001) and WIT were both lower in the Veriset™ group (14.6 min vs. 20.6 min; p = 0.01). No differences in surgical margins (p = 0.602) and overall complication rates at 30 (p = 0.599) and 90 days (p = 0.611) postoperatively were noticed. The surgical outcome according to “trifecta” was achieved in 65% of patients using Veriset™ and in 57.5% of patients by suture closure, respectively. CONCLUSION: The hemostatic Veriset™ patch can successfully be implemented in LPN. Handling and application appear favorable, thereby reducing operation time and WIT. The present results suggest that the device may represent an alternative to parenchyma suturing in LPN. |
format | Online Article Text |
id | pubmed-8741715 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-87417152022-01-20 Versatility and clinical effectiveness of a synthetic sealing hemostatic patch as alternative to parenchyma suturing in laparoscopic partial nephrectomy Erne, Eva Kruck, Stephan Todenhoefer, Tilman Aufderklamm, Stefan Amend, Bastian Bedke, Jens Stenzl, Arnulf Rausch, Steffen Surg Endosc Article BACKGROUND: Improvements in laparoscopic partial nephrectomy (LPN) in order to minimize perioperative warm ischemia time (WIT), complications, and consequently patient outcome are desirable. Veriset™ is a ready-to-use hemostatic patch of absorbable oxidized cellulose and hydrogel components that has earlier been implemented in vascular and hepatic surgery. We report our experience using this device in LPN. METHODS: Patients with a solitary malignant renal mass suspicious for renal cancer underwent LPN with either the use of Veriset™ hemostatic patch (n = 40) or conventional suture technique (n = 40). Patient characteristics, operation time and WIT, postoperative course and complications were recorded retrospectively. Tumor complexity was calculated according to the R.E.N.A.L. score. Outcome was determined according to the “trifecta” criteria (negative surgical margin, WIT < 25 min, no complications within 30 days). RESULTS: No significant differences with regard to clinical parameters and median R.E.N.A.L. score (6) were observed between both groups. Operation time (mean 127.1 min vs. 162. 8 min; p = 0.001) and WIT were both lower in the Veriset™ group (14.6 min vs. 20.6 min; p = 0.01). No differences in surgical margins (p = 0.602) and overall complication rates at 30 (p = 0.599) and 90 days (p = 0.611) postoperatively were noticed. The surgical outcome according to “trifecta” was achieved in 65% of patients using Veriset™ and in 57.5% of patients by suture closure, respectively. CONCLUSION: The hemostatic Veriset™ patch can successfully be implemented in LPN. Handling and application appear favorable, thereby reducing operation time and WIT. The present results suggest that the device may represent an alternative to parenchyma suturing in LPN. Springer US 2021-02-16 2022 /pmc/articles/PMC8741715/ /pubmed/33591449 http://dx.doi.org/10.1007/s00464-021-08333-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Erne, Eva Kruck, Stephan Todenhoefer, Tilman Aufderklamm, Stefan Amend, Bastian Bedke, Jens Stenzl, Arnulf Rausch, Steffen Versatility and clinical effectiveness of a synthetic sealing hemostatic patch as alternative to parenchyma suturing in laparoscopic partial nephrectomy |
title | Versatility and clinical effectiveness of a synthetic sealing hemostatic patch as alternative to parenchyma suturing in laparoscopic partial nephrectomy |
title_full | Versatility and clinical effectiveness of a synthetic sealing hemostatic patch as alternative to parenchyma suturing in laparoscopic partial nephrectomy |
title_fullStr | Versatility and clinical effectiveness of a synthetic sealing hemostatic patch as alternative to parenchyma suturing in laparoscopic partial nephrectomy |
title_full_unstemmed | Versatility and clinical effectiveness of a synthetic sealing hemostatic patch as alternative to parenchyma suturing in laparoscopic partial nephrectomy |
title_short | Versatility and clinical effectiveness of a synthetic sealing hemostatic patch as alternative to parenchyma suturing in laparoscopic partial nephrectomy |
title_sort | versatility and clinical effectiveness of a synthetic sealing hemostatic patch as alternative to parenchyma suturing in laparoscopic partial nephrectomy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741715/ https://www.ncbi.nlm.nih.gov/pubmed/33591449 http://dx.doi.org/10.1007/s00464-021-08333-0 |
work_keys_str_mv | AT erneeva versatilityandclinicaleffectivenessofasyntheticsealinghemostaticpatchasalternativetoparenchymasuturinginlaparoscopicpartialnephrectomy AT kruckstephan versatilityandclinicaleffectivenessofasyntheticsealinghemostaticpatchasalternativetoparenchymasuturinginlaparoscopicpartialnephrectomy AT todenhoefertilman versatilityandclinicaleffectivenessofasyntheticsealinghemostaticpatchasalternativetoparenchymasuturinginlaparoscopicpartialnephrectomy AT aufderklammstefan versatilityandclinicaleffectivenessofasyntheticsealinghemostaticpatchasalternativetoparenchymasuturinginlaparoscopicpartialnephrectomy AT amendbastian versatilityandclinicaleffectivenessofasyntheticsealinghemostaticpatchasalternativetoparenchymasuturinginlaparoscopicpartialnephrectomy AT bedkejens versatilityandclinicaleffectivenessofasyntheticsealinghemostaticpatchasalternativetoparenchymasuturinginlaparoscopicpartialnephrectomy AT stenzlarnulf versatilityandclinicaleffectivenessofasyntheticsealinghemostaticpatchasalternativetoparenchymasuturinginlaparoscopicpartialnephrectomy AT rauschsteffen versatilityandclinicaleffectivenessofasyntheticsealinghemostaticpatchasalternativetoparenchymasuturinginlaparoscopicpartialnephrectomy |